Public Employees Retirement System of Ohio Sells 164,117 Shares of Certara, Inc. $CERT

Public Employees Retirement System of Ohio lessened its holdings in Certara, Inc. (NASDAQ:CERT) by 82.5% during the 1st quarter, Holdings Channel.com reports. The firm owned 34,802 shares of the company’s stock after selling 164,117 shares during the period. Public Employees Retirement System of Ohio’s holdings in Certara were worth $198,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently made changes to their positions in the company. UBS Group AG increased its holdings in Certara by 50.7% during the fourth quarter. UBS Group AG now owns 2,489,603 shares of the company’s stock valued at $21,933,000 after buying an additional 837,648 shares during the last quarter. Granite Investment Partners LLC bought a new position in Certara in the first quarter worth approximately $2,130,000. Dimensional Fund Advisors LP boosted its stake in shares of Certara by 2.1% during the 1st quarter. Dimensional Fund Advisors LP now owns 8,562,508 shares of the company’s stock worth $48,806,000 after acquiring an additional 175,024 shares during the last quarter. Jefferies Financial Group Inc. bought a new stake in shares of Certara during the 4th quarter valued at $26,706,000. Finally, Y Intercept Hong Kong Ltd bought a new stake in shares of Certara during the 1st quarter valued at $1,980,000. Hedge funds and other institutional investors own 73.96% of the company’s stock.

Certara News Summary

Here are the key news stories impacting Certara this week:

• Positive Sentiment: Certara completed its previously authorized $100 million share-repurchase program, and its board approved an additional $50 million for buybacks. The expanded repurchase authorization may support earnings per share and signal management confidence in the stock. Certara Reports Second Quarter 2026 Financial Results
• Positive Sentiment: Management reaffirmed its 2026 revenue guidance. The earnings discussion also highlighted relative strength in Certara’s software business, which helped offset pressure in its services operations. Certara Earnings Call: Software Strength Amid Services Strain
• Neutral Sentiment: Certara appointed Julien Perrier as chief commercial officer, representing a leadership transition in a role important to sales execution and growth. The longer-term effect will depend on whether the change improves commercial momentum. Certara Announces Leadership Change in Commercial Executive Role
• Negative Sentiment: Second-quarter revenue was $93.27 million, below the $98.09 million consensus and down 10.8% year over year. Adjusted earnings of $0.08 per share also missed estimates of approximately $0.09 to $0.10, although EPS improved from $0.07 a year earlier. Certara Q2 Earnings and Revenues Lag Estimates
• Negative Sentiment: Barclays raised its price target from $6.50 to $7.50 but retained an equal-weight rating, implying analysts see limited upside after the recent rebound. Barclinga analyst action

Analysts Set New Price Targets

CERT has been the topic of a number of recent research reports. Craig Hallum decreased their target price on Certara from $10.00 to $8.00 and set a “hold” rating on the stock in a report on Tuesday, May 12th. BMO Capital Markets reduced their price target on Certara from $7.00 to $6.00 and set a “market perform” rating for the company in a research report on Tuesday, May 12th. Weiss Ratings restated a “sell (e+)” rating on shares of Certara in a research report on Friday, May 29th. Barclays raised their price objective on Certara from $6.50 to $7.50 and gave the stock an “equal weight” rating in a research note on Wednesday. Finally, Robert W. Baird cut their price objective on Certara from $7.00 to $6.00 and set a “neutral” rating for the company in a research note on Tuesday, May 12th. One equities research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $8.95.

Certara Trading Up 2.7%

Shares of Certara stock opened at $8.01 on Thursday. The company has a market capitalization of $1.25 billion, a P/E ratio of -17.80 and a beta of 1.44. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.88 and a current ratio of 2.55. The company has a fifty day moving average of $6.47 and a 200 day moving average of $6.55. Certara, Inc. has a fifty-two week low of $4.45 and a fifty-two week high of $13.88.

Certara (NASDAQ:CERT) last posted its quarterly earnings results on Tuesday, August 4th. The company reported $0.08 EPS for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.01). Certara had a negative net margin of 16.75% and a positive return on equity of 3.86%. The business had revenue of $93.27 million for the quarter, compared to the consensus estimate of $98.09 million. During the same period in the prior year, the business earned $0.07 earnings per share. Certara’s revenue was down 10.8% compared to the same quarter last year. On average, sell-side analysts anticipate that Certara, Inc. will post 0.24 earnings per share for the current fiscal year.

Certara Profile

Certara is a biosimulation software and services company that partners with pharmaceutical, biotechnology and medical device developers to accelerate drug discovery, development and regulatory approval. The company’s platform integrates quantitative pharmacology, real-world evidence, artificial intelligence and machine learning to model and simulate drug behavior across a range of therapeutic areas and patient populations. By applying these mechanistic and data-driven approaches, Certara helps its clients predict clinical outcomes, optimize dosing strategies and streamline decision-making throughout the product lifecycle.

The company’s offerings are divided into software tools and consulting services.